These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9413086)

  • 41. [Isolation of a highly purified capsular polysaccharide from Salmonella enterica serovar Typhi (Salmonella typhi)--Vi-antigen and its use in serological diagnosis of typhoid fever].
    Tesheva AM; Aparin PG; L'vov VL
    Bioorg Khim; 2002; 28(1):64-8. PubMed ID: 11875976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Emergency prophylaxis of typhoid using the Vi-antigen of typhoid bacteria].
    D'iachenko PN; Dzhumaliev ND; Il'in VI; Pavlova TE
    Zdravookhr Kirg; 1976; (6):32-5. PubMed ID: 13578
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of future formulations of Ty21a Salmonella typhi vaccines in endemic areas.
    Arya SC
    Vaccine; 1990 Dec; 8(6):612. PubMed ID: 2087881
    [No Abstract]   [Full Text] [Related]  

  • 44. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).
    Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
    Vaccine; 1999 Aug; 17(23-24):2941-5. PubMed ID: 10462227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH; Wu CG; Xie GZ; Gu QW; Wang BR; Wang LY; Wang HF; Ding ZS; Yang Y; Tan WS; Wang WY; Wang XC; Qin M; Wang JH; Tang HA; Jiang XM; Li YH; Wang ML; Zhang SL; Li GL
    Bull World Health Organ; 2001; 79(7):625-31. PubMed ID: 11477965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Jin C; Gibani MM; Moore M; Juel HB; Jones E; Meiring J; Harris V; Gardner J; Nebykova A; Kerridge SA; Hill J; Thomaides-Brears H; Blohmke CJ; Yu LM; Angus B; Pollard AJ
    Lancet; 2017 Dec; 390(10111):2472-2480. PubMed ID: 28965718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential and limitations of polysaccharide vaccines in infancy.
    Cadoz M
    Vaccine; 1998; 16(14-15):1391-5. PubMed ID: 9711777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination against intracellular bacterial pathogens.
    Pang T
    Trends Microbiol; 1998 Nov; 6(11):433. PubMed ID: 9846359
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of Vi polysaccharide vaccine against Salmonella typhi.
    Arya SC
    Vaccine; 1999 Mar; 17(9-10):1015-6. PubMed ID: 10195609
    [No Abstract]   [Full Text] [Related]  

  • 53. A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.
    Szu SC; Hunt S; Xie G; Robbins JB; Schneerson R; Gupta RK; Zhao Z; Tan X
    Vaccine; 2013 Apr; 31(15):1970-4. PubMed ID: 23422143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.
    Santander J; Roland KL; Curtiss R
    J Infect Dev Ctries; 2008 Dec; 2(6):412-20. PubMed ID: 19745516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccines for preventing typhoid fever.
    Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Salmonella Typhi lipopolysaccharide O and capsular polysaccharide Vi antigens in persons from outbreak of typhoid fever].
    Rastawicki W; Kałużewski S
    Med Dosw Mikrobiol; 2015; 67(3-4):165-71. PubMed ID: 27019910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
    Saxena M; Percheson PB; Di Fabio JL
    J Infect Dis; 1993 Aug; 168(2):522-3. PubMed ID: 8336003
    [No Abstract]   [Full Text] [Related]  

  • 60. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
    Sánchez-Ramón S; de Gracia J; García-Alonso AM; Rodríguez Molina JJ; Melero J; de Andrés A; García Ruiz de Morales JM; Ferreira A; Ocejo-Vinyals JG; Cid JJ; García Martínez JM; Lasheras T; Vargas ML; Gil-Herrera J; García Rodríguez MC; Castañer JL; González Granado LI; Allende LM; Soler-Palacin P; Herráiz L; López Hoyos M; Bellón JM; Silva G; Gurbindo DM; Carbone J; Rodríguez-Sáinz C; Matamoros N; Parker AR; Fernández-Cruz E;
    Clin Immunol; 2016 Aug; 169():80-84. PubMed ID: 27236002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.